Gilat Q2 Underscores Organic Momentum, but Deal Closure and Margins Still the Real Story

What happened

Gilat Satellite Networks reported Q2 2026 results featuring 17% year-over-year revenue growth and a 31% jump in adjusted EBITDA, driven by a mix shift toward higher-margin integrated solutions. The pending $157.5 million acquisition of Comtech’s satellite and space communications segment remains on track for a year-end close and is expected to double defense revenue, broadening the technology portfolio and enabling larger contract bids. While the quarter’s numbers confirm healthy demand in in-flight connectivity and defense, they do not yet resolve the overhang from depressed Commercial gross margins (27% in FY2025) and the deal’s regulatory clearance risk. Chairman and CEO Adi Sfadia touted the results as evidence that Gilat’s multi-orbit, multi-network strategy is working, but investors should note that the stock has already rallied sharply from its 2025 lows. The narrative now requires proof that the Comtech integration will proceed smoothly and that the recent margin improvements are sustainable beyond the quarter.

Implication

The Q2 beat supports the view that Gilat’s core businesses are firing, but the stock’s next leg up depends on clearing two hurdles: a clean Comtech acquisition closing by end-2026 and Commercial segment gross margins climbing back above 30% on a sustained basis. Until there is public evidence of HSR and CFIUS progress, the deal’s completion remains uncertain, and the recent insider selling by the CEO and CLO adds a layer of caution. On the positive side, the push into integrated solutions improves margin mix, yet it also raises the complexity of execution. Investors should monitor the 90-day checkpoint for deal-process updates and any revision to Sidewinder delivery schedules, as these will signal whether the organic growth narrative can hold without the acquisition. At current levels, the risk/reward is balanced; a better entry point near $10.50 would offer a more attractive margin of safety.

Thesis delta

The Q2 print does not alter the WAIT rating. It provides incremental confirmation of organic demand but does not move the needle on the two critical unresolved items: the Comtech deal’s regulatory pathway and the Commercial division’s margin recovery. The thesis’s risk/reward remains balanced, with an attractive entry still seen around $10.50.